Literature DB >> 4960936

Estimation of rapidly exchangeable cellular thyroxine from the plasma disappearance curves of simultaneously administered thyroxine-131-I and albumin-125-I.

J H Oppenheimer, G Bernstein, J Hasen.   

Abstract

A mathematical analysis of the plasma disappearance curves of simultaneously injected thyroxine-(131)I and albumin-(125)I allows the development of simple formulas for estimating the pool size and transfer kinetics of rapidly exchangeable intracellular thyroxine in man. Evidence is presented that the early distribution kinetics of albumin-(125)I can be used to represent the expansion of the thyroxine-(131)I-plasma protein complex into the extracellular compartment. Calculations indicate that approximately 37% of total body extrathyroidal thyroxine is within such exchangeable tissue stores. The average cellular clearance of thyroxine is 42.7 ml per minute, a value far in excess of the metabolic clearance of this hormone. Results of external measurements over the hepatic area and studies involving hepatic biopsies indicate that the liver is an important but probably not the exclusive component of the intracellular compartment. The partition of thyroxine between cellular and extracellular compartments is determined by the balance of tissue and plasma protein binding factors. The fractional transfer constants are inversely related to the strength of binding of each compartment and directly proportional to the permeability characteristic of the hypothetical membrane separating compartments. Appropriate numerical values for these factors are assigned. An increased fractional entrance of thyroxine-(131)I into the cellular compartment was noted in a patient with congenital decrease in the maximal binding capacity of thyroxine-binding globulin and in three patients after the infusion of 5,5-diphenylhydantoin. Decreased intracellular space and impaired permeability characteristics were observed in five patients with hepatic disease. Studies of the rate of entrance of thyroxine-(131)I and albumin-(125)I into the pleural effusion of a patient with congestive heart failure suggested that transcapillary passage of thyroxine independent of its binding protein is not a predominant factor in the total distribution kinetics of thyroxine-(131)I. The thesis is advanced that the distribution of thyroxine, both within the extracellular compartment and between the extracellular and intracellular compartments, is accomplished largely by the carrier protein and the direct transfer of thyroxine from one binding site to another. The concept of free thyroxine is reassessed in terms of this formulation.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4960936      PMCID: PMC297079          DOI: 10.1172/JCI105577

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Studies of I-131-albumin catabolism and distribution in normal young male adults.

Authors:  W L BEEKEN; W VOLWILER; P D GOLDSWORTHY; L E GARBY; W E REYNOLDS; R STOGSDILL; R S STEMLER
Journal:  J Clin Invest       Date:  1962-06       Impact factor: 14.808

2.  Depression of the serum protein-bound iodine level by diphenylhydantion.

Authors:  J H OPPENHEIMER; L V FISHER; K M NELSON; J W JAILER
Journal:  J Clin Endocrinol Metab       Date:  1961-03       Impact factor: 5.958

3.  A practical method for plasma albumin turnover studies.

Authors:  J D PEARSON; N VEALL; H VETTER
Journal:  Strahlentherapie       Date:  1958

4.  The iodide trapping and binding functions of the thyroid.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

5.  The kinetics of distribution between plasma and liver of 131-I-labeled L-thyroxine in man: observations of subjects with normal and decreased serum thyroxine-binding globulin.

Authors:  R R Cavalieri; G L Searle
Journal:  J Clin Invest       Date:  1966-06       Impact factor: 14.808

6.  Free thyroxine in human serum: simplified measurement with the aid of magnesium precipitation.

Authors:  K Sterling; M A Brenner
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

7.  An analysis of published data on thyroxine turnover in human subjects.

Authors:  T H Oddie; J H Meade; D A Fisher
Journal:  J Clin Endocrinol Metab       Date:  1966-04       Impact factor: 5.958

8.  METABOLISM OF IODINE-131--LABELED THYROXINE-BINDING PREALBUMIN IN MAN.

Authors:  J H OPPEHNEIMER; M I SURKS; G BERNSTEIN; J C SMITY
Journal:  Science       Date:  1965-08-13       Impact factor: 47.728

9.  Preparation of I-131-labeled human serum prealbumin and its metabolism in normal and sick patients.

Authors:  E L Socolow; K A Woeber; R H Purdy; M T Holloway; S H Ingbar
Journal:  J Clin Invest       Date:  1965-10       Impact factor: 14.808

10.  The localization of homolgous plasma proteins in the tissues of young human beings as demonstrated with fluorescent antibodies.

Authors:  D GITIL; B H LANDING; A WHIPPLE
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

View more
  22 in total

1.  The interpretation of the serum protein-bound iodine: A review.

Authors:  J D Acland
Journal:  J Clin Pathol       Date:  1971-04       Impact factor: 3.411

2.  Estimation of thyroxine distribution in man.

Authors:  J T Nicoloff; J T Dowling
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

3.  Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man.

Authors:  M Inada; K Kasagi; S Kurata; Y Kazama; H Takayama; K Torizuka; M Fukase; T Soma
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

4.  Thyroxine transport and distribution in Nagase analbuminemic rats.

Authors:  C M Mendel; R R Cavalieri; L A Gavin; T Pettersson; M Inoue
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

5.  A functional model of early thyroxine distribution in man.

Authors:  L Benetazzo; B Busnardo; G Clemente
Journal:  Med Biol Eng       Date:  1972-05

6.  Relative rates of transcapillary movement of free thyroxine, protein-bound thyroxine, thyroxine-binding proteins, and albumin.

Authors:  C H Irvine; M W Simpson-Morgan
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

7.  The distribution kinetics of triiodothyronine: studies of euthyroid subjects with decreased plasma thyroxine-binding globulin and patients with Graves' disease.

Authors:  R R Cavalieri; M Steinberg; G L Searle
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

8.  The effects of an acute load of thyroxine on the transport and peripheral metabolism of triiodothyronine in man.

Authors:  K A Woeber; E Hecker; S H Ingbar
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

9.  Role of serum carrier proteins in the peripheral metabolism and tissue distribution of thyroid hormones in familial dysalbuminemic hyperthyroxinemia and congenital elevation of thyroxine-binding globulin.

Authors:  R Bianchi; G Iervasi; A Pilo; F Vitek; M Ferdeghini; F Cazzuola; G Giraudi
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

10.  Thyroid hormone transport in the serum of patients with thyrotoxic Graves' disease before and after treatment.

Authors:  L E Braverman; A E Foster; S H Ingbar
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.